Mohamed S. Alesawy

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: <i>in-vitro</i> anticancer evaluation and <i>in-silico</i> studies

Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 99 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2

Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed et al. · Bioorganic Chemistry · 2022 · 92 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists

Mohamed K. Ibrahim, Ibrahim H. Eissa, Mohamed S. Alesawy et al. · Bioorganic & Medicinal Chemistry · 2017 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design and discovery of new 1,2,4‐triazolo[4,3‐<i>c</i>]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

Mohamed S. Alesawy, Ahmed A. Al‐Karmalawy, Eslam B. Elkaeed et al. · Archiv der Pharmazie · 2020 · 76 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4′,3′-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies

Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Mohamed S. Alesawy et al. · Bioorganic & Medicinal Chemistry · 2020 · 65 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12